-
1
-
-
0013877409
-
Quantitative relationship between circulating leukocytes and infection in patients with acute leukemia
-
Bodey GP, Buckley M, Sathe YS et al (1996) Quantitative relationship between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64:328-340
-
(1996)
Ann Intern Med
, vol.64
, pp. 328-340
-
-
Bodey, G.P.1
Buckley, M.2
Sathe, Y.S.3
-
2
-
-
0015221860
-
Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia
-
10.1056/NEJM197105132841904
-
Schimpff S, Satterlee W, Young VM et al (1971) Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med 284:161-165
-
(1971)
N Engl J Med
, vol.284
, pp. 161-165
-
-
Schimpff, S.1
Satterlee, W.2
Young, V.M.3
-
3
-
-
0020730359
-
Empiric treatment of infections in neutropenic patients with cancer
-
6342096 10.1093/clinids/5.Supplement-1.S21
-
Klastersky J (1983) Empiric treatment of infections in neutropenic patients with cancer. Rev Infect Dis 5:S21-S23
-
(1983)
Rev Infect Dis
, vol.5
-
-
Klastersky, J.1
-
4
-
-
0023551772
-
Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia
-
The EORTC International Antimicrobial Therapy Cooperative Group
-
The EORTC International Antimicrobial Therapy Cooperative Group (1978) Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia. N Engl J Med 317:1692-1698
-
(1978)
N Engl J Med
, vol.317
, pp. 1692-1698
-
-
-
5
-
-
0026599442
-
Risk assessment in cancer patients with fever and neutropenia: A prospective, two-center validation of a prediction rule
-
1732432 1:STN:280:DyaK387itF2ntw%3D%3D
-
Talcott JA, Siegel RD, Finberg R et al (1992) Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule. J Clin Oncol 10:316-322
-
(1992)
J Clin Oncol
, vol.10
, pp. 316-322
-
-
Talcott, J.A.1
Siegel, R.D.2
Finberg, R.3
-
6
-
-
0027976188
-
Home antibiotic-therapy for low-risk cancer patients with fever and neutropenia - A pilot-study of 30 patients based on a validated prediction rule
-
8270967 1:STN:280:DyaK2c%2Fps1Sntg%3D%3D
-
Talcott JA, Whalen A, Clark J et al (1994) Home antibiotic-therapy for low-risk cancer patients with fever and neutropenia-a pilot-study of 30 patients based on a validated prediction rule. J Clin Oncol 12:107-114
-
(1994)
J Clin Oncol
, vol.12
, pp. 107-114
-
-
Talcott, J.A.1
Whalen, A.2
Clark, J.3
-
7
-
-
0033614926
-
Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy
-
10.1056/NEJM199907293410502
-
Kern WV, Cometta A, De Bock R et al (1999) Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. N Engl J Med 314:312-318
-
(1999)
N Engl J Med
, vol.314
, pp. 312-318
-
-
Kern, W.V.1
Cometta, A.2
De Bock, R.3
-
8
-
-
0033615008
-
A double blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy
-
10423464 10.1056/NEJM199907293410501 1:CAS:528:DyaK1MXltVKgs7w%3D
-
Freifeld A, Marchigiani D, Walsh T et al (1999) A double blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy. N Engl J Med 341:305-3011
-
(1999)
N Engl J Med
, vol.341
, pp. 305-3011
-
-
Freifeld, A.1
Marchigiani, D.2
Walsh, T.3
-
9
-
-
0033904644
-
The multinational association for supportive care in cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients
-
10944139 1:STN:280:DC%2BD3cvivFCrsg%3D%3D
-
Klastersky J, Paesmans M, Rubenstein EB et al (2000) The multinational association for supportive care in cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 18:3038-3051
-
(2000)
J Clin Oncol
, vol.18
, pp. 3038-3051
-
-
Klastersky, J.1
Paesmans, M.2
Rubenstein, E.B.3
-
10
-
-
77954338016
-
Management of febrile neutropenia: ESMO Clinical Practice Guidelines
-
10.1093/annonc/mdq196
-
Naurois J, Novitzky-Basso I, Gill JM et al (2010) Management of febrile neutropenia: ESMO Clinical Practice Guidelines. Ann Oncol 21:252-256
-
(2010)
Ann Oncol
, vol.21
, pp. 252-256
-
-
Naurois, J.1
Novitzky-Basso, I.2
Gill, J.M.3
-
11
-
-
0037087226
-
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
-
11850858 10.1086/339215
-
Hughes WT, Amstrong D, Bodey GP et al (2002) 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34:730-751
-
(2002)
Clin Infect Dis
, vol.34
, pp. 730-751
-
-
Hughes, W.T.1
Amstrong, D.2
Bodey, G.P.3
-
12
-
-
79951816939
-
Executive summary: Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by infectious diseases society of America
-
21258094 10.1093/cid/cir073
-
Freifeld A, Bow E, Sepkowitz K et al (2011) Executive summary: clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by infectious diseases society of America. Clin Infect Dis 52:e56-e93
-
(2011)
Clin Infect Dis
, vol.52
-
-
Freifeld, A.1
Bow, E.2
Sepkowitz, K.3
-
13
-
-
4043155814
-
Febrile neutropenia: A prospective study to validate the Multinational Association of Supportive Care of Cancer (MASCC) risk index score
-
15197637 10.1007/s00520-004-0614-5
-
Uys A, Rapoport B, Anderson R (2004) Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care of Cancer (MASCC) risk index score. Support Care Cancer 12:555-560
-
(2004)
Support Care Cancer
, vol.12
, pp. 555-560
-
-
Uys, A.1
Rapoport, B.2
Anderson, R.3
-
14
-
-
33644554514
-
The feasibility of early hospital discharge with oral antimicrobial therapy in low risk patients with febrile neutropenia following chemotherapy for hematologic malignancies
-
16461306
-
Cherif H, Johansson E, Björkholm M et al (2006) The feasibility of early hospital discharge with oral antimicrobial therapy in low risk patients with febrile neutropenia following chemotherapy for hematologic malignancies. Haematologica 91:215-222
-
(2006)
Haematologica
, vol.91
, pp. 215-222
-
-
Cherif, H.1
Johansson, E.2
Björkholm, M.3
-
15
-
-
44449120171
-
Applying the Multinational Association for Supportive Care in Cancer risk scoring in predicting outcome of febrile neutropenia patients in a cohort of patients
-
18437382 10.1007/s00277-008-0487-7
-
Baskaran ND, Gan GG, Adeeba K (2008) Applying the Multinational Association for Supportive Care in Cancer risk scoring in predicting outcome of febrile neutropenia patients in a cohort of patients. Ann Hematol 87:563-569
-
(2008)
Ann Hematol
, vol.87
, pp. 563-569
-
-
Baskaran, N.D.1
Gan, G.G.2
Adeeba, K.3
-
16
-
-
80052448364
-
Prediction of outcome in cancer patients with febrile neutropenia: A prospective validation of the Multinational Association for Supportive Care in Cancer risk index in a Chinese population and comparison with the Talcott model and artificial neural network
-
10.1007/s00520-010-0993-8
-
Pun Hui E, Leung KS, Poon T et al (2011) Prediction of outcome in cancer patients with febrile neutropenia: a prospective validation of the Multinational Association for Supportive Care in Cancer risk index in a Chinese population and comparison with the Talcott model and artificial neural network. Support Care Cancer 19:1625-1635
-
(2011)
Support Care Cancer
, vol.19
, pp. 1625-1635
-
-
Pun Hui, E.1
Leung, K.S.2
Poon, T.3
-
17
-
-
80052023969
-
Prognostic evaluation of febrile neutropaenia in apparently stable adult cancer patient
-
21811253 10.1038/bjc.2011.284 1:STN:280:DC%2BC3Mjot1Oqtw%3D%3D
-
Carmona-Bayonas A, Gómez J, González-Billalabeitia E et al (2011) Prognostic evaluation of febrile neutropaenia in apparently stable adult cancer patient. Br J Cancer 105:612-617
-
(2011)
Br J Cancer
, vol.105
, pp. 612-617
-
-
Carmona-Bayonas, A.1
Gómez, J.2
González-Billalabeitia, E.3
-
18
-
-
84855894765
-
Systematic review and meta-analysis of the value of initial biomarkers in predicting adverse outcome in febrile neutropenic episodes in children and young people with cancer
-
10.1186/1741-7015-10-6
-
Philips R, Wade R, Lehrnbecher T et al (2012) Systematic review and meta-analysis of the value of initial biomarkers in predicting adverse outcome in febrile neutropenic episodes in children and young people with cancer. BMC Med 10:6
-
(2012)
BMC Med
, vol.10
, pp. 6
-
-
Philips, R.1
Wade, R.2
Lehrnbecher, T.3
-
19
-
-
80051596932
-
Predicting febrile neutropenic patients at low risk using the MASCC score: Does bacteremia matter?
-
20596732 10.1007/s00520-010-0925-7
-
Paesmans M, Klastersky J, Maertens J et al (2011) Predicting febrile neutropenic patients at low risk using the MASCC score: does bacteremia matter? Support Care Cancer 19:1001-1008
-
(2011)
Support Care Cancer
, vol.19
, pp. 1001-1008
-
-
Paesmans, M.1
Klastersky, J.2
Maertens, J.3
-
20
-
-
0036234739
-
Monotherapy or aminoglycoside containing combinations for empirical antibiotic treatment of febrile neutropenia patients: A meta-analysis
-
1:CAS:528:DC%2BD38Xjtlent7w%3D
-
Furno P, Bucaneve G, Del Favero A (2002) Monotherapy or aminoglycoside containing combinations for empirical antibiotic treatment of febrile neutropenia patients: a meta-analysis. Lancet 2:231-243
-
(2002)
Lancet
, vol.2
, pp. 231-243
-
-
Furno, P.1
Bucaneve, G.2
Del Favero, A.3
-
21
-
-
43549085918
-
Antibiothérapie empirique lors de neutropénie febrile
-
18578432 1:STN:280:DC%2BD1cvhtVSgsg%3D%3D
-
Kridel R, Van Delden C, Calandra T et al (2008) Antibiothérapie empirique lors de neutropénie febrile. Rev Med Suisse 4:914-919
-
(2008)
Rev Med Suisse
, vol.4
, pp. 914-919
-
-
Kridel, R.1
Van Delden, C.2
Calandra, T.3
-
22
-
-
77950162473
-
Antibiotic management of febrile neutropenia: Current developments and future directions
-
20227985 1:CAS:528:DC%2BC3cXlsFSqs7o%3D
-
Mebis J, Goossens H, Berneman ZN (2010) Antibiotic management of febrile neutropenia: current developments and future directions. J Chemother 22:5-12
-
(2010)
J Chemother
, vol.22
, pp. 5-12
-
-
Mebis, J.1
Goossens, H.2
Berneman, Z.N.3
-
23
-
-
77953051426
-
Neutropénie fébrile chez le patient adulte atteint de tumeur solide: Revue de la littérature pour une gestion rationnelle et optimale
-
Event C, Taillade L, Spano JP et al (2010) Neutropénie fébrile chez le patient adulte atteint de tumeur solide: revue de la littérature pour une gestion rationnelle et optimale. Bull Cancer 97:547-557
-
(2010)
Bull Cancer
, vol.97
, pp. 547-557
-
-
Event, C.1
Taillade, L.2
Spano, J.P.3
-
24
-
-
79251535327
-
Use of empiric antimicrobial therapy in neutropenic fever
-
21272173 10.1111/j.1445-5994.2010.02340.x 1:CAS:528:DC%2BC3MXivFWht7c%3D
-
Tam CS, O'Reilly M, Andresen D et al (2011) Use of empiric antimicrobial therapy in neutropenic fever. Intern Med J 41:90-101
-
(2011)
Intern Med J
, vol.41
, pp. 90-101
-
-
Tam, C.S.1
O'Reilly, M.2
Andresen, D.3
-
25
-
-
71349083356
-
Oral moxifloxacin for outpatients treatment of low-risk, febrile neutropenic patients
-
19387695 10.1007/s00520-009-0634-2
-
Rolston K, Frisbee-Hume S, Patel S et al (2010) Oral moxifloxacin for outpatients treatment of low-risk, febrile neutropenic patients. Support Care Cancer 18:89-94
-
(2010)
Support Care Cancer
, vol.18
, pp. 89-94
-
-
Rolston, K.1
Frisbee-Hume, S.2
Patel, S.3
-
26
-
-
38049141184
-
Compliance with a critical pathway for the management of febrile neutropenia and impact on clinical outcomes
-
17938926 10.1007/s00277-007-0390-7 1:STN:280:DC%2BD1c%2Fgs1yluw%3D%3D
-
Zuckermann J, Moreira L, Stoll P (2008) Compliance with a critical pathway for the management of febrile neutropenia and impact on clinical outcomes. Ann Hematol 87:139-145
-
(2008)
Ann Hematol
, vol.87
, pp. 139-145
-
-
Zuckermann, J.1
Moreira, L.2
Stoll, P.3
-
27
-
-
49349090753
-
Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge
-
18197434 10.1007/s00520-007-0383-z
-
Sebban C, Dussart S, Fuhrmann C et al (2008) Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge. Support Care Cancer 16:1017-1023
-
(2008)
Support Care Cancer
, vol.16
, pp. 1017-1023
-
-
Sebban, C.1
Dussart, S.2
Fuhrmann, C.3
-
28
-
-
0042846028
-
Oral antibiotics with early hospital discharge compared with in-patients intravenous antibiotics for low-risk febrile neutropenia in patients with cancer: A prospective randomized controlled single centre study
-
12838298 10.1038/sj.bjc.6600993 1:CAS:528:DC%2BD3sXltVWms7c%3D
-
Innes HE, Smith DB, O'Reilly SM et al (2003) Oral antibiotics with early hospital discharge compared with in-patients intravenous antibiotics for low-risk febrile neutropenia in patients with cancer: a prospective randomized controlled single centre study. Br J Cancer 89:43-49
-
(2003)
Br J Cancer
, vol.89
, pp. 43-49
-
-
Innes, H.E.1
Smith, D.B.2
O'Reilly, S.M.3
-
29
-
-
41849097436
-
Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: Feasibility and safety in routine clinical practice
-
17899215 10.1007/s00520-007-0334-8
-
Innes H, Lim S, Hall A et al (2008) Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice. Support Care Cancer 16:485-4941
-
(2008)
Support Care Cancer
, vol.16
, pp. 485-4941
-
-
Innes, H.1
Lim, S.2
Hall, A.3
-
30
-
-
33748661910
-
Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications
-
16943529 10.1200/JCO.2005.03.9909 1:CAS:528:DC%2BD28XhtVantbrP
-
Klastersky J, Paesmans M, Georgala A et al (2006) Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications. J Clin Oncol 24:4129-4134
-
(2006)
J Clin Oncol
, vol.24
, pp. 4129-4134
-
-
Klastersky, J.1
Paesmans, M.2
Georgala, A.3
-
31
-
-
84861097138
-
First-day step-down to oral outpatient treatment versus continued standard treatment in children with cancer and low-risk fever in neutropenia. A randomized controlled trial within the multicenter SPOG 2003 FN study
-
10.1002/pbc.24076 22271702 10.1002/pbc.24076
-
Brack E, Bodmer N, Simon A et al (2012) First-day step-down to oral outpatient treatment versus continued standard treatment in children with cancer and low-risk fever in neutropenia. A randomized controlled trial within the multicenter SPOG 2003 FN study. Pediatr Blood Cancer 59(3):423-430. doi: 10.1002/pbc.24076
-
(2012)
Pediatr Blood Cancer
, vol.59
, Issue.3
, pp. 423-430
-
-
Brack, E.1
Bodmer, N.2
Simon, A.3
-
32
-
-
45249110692
-
Outpatient management of febrile neutropenia: Time to revise the present treatment strategy
-
18551855 1:CAS:528:DC%2BD1cXnsVKksL8%3D
-
Carstensen M, Sorensen JB (2008) Outpatient management of febrile neutropenia: time to revise the present treatment strategy. J Support Oncol 6:199-208
-
(2008)
J Support Oncol
, vol.6
, pp. 199-208
-
-
Carstensen, M.1
Sorensen, J.B.2
-
33
-
-
79955481040
-
Outpatient management of cancer patients with febrile neutropenia: A systematic review and meta-analysis
-
21363878 10.1093/annonc/mdq745 1:STN:280:DC%2BC3MbjsV2ksQ%3D%3D
-
Teuffel O, Ethier MC, Alibhal SM et al (2011) Outpatient management of cancer patients with febrile neutropenia: a systematic review and meta-analysis. Ann Oncol 22:2358-2365
-
(2011)
Ann Oncol
, vol.22
, pp. 2358-2365
-
-
Teuffel, O.1
Ethier, M.C.2
Alibhal, S.M.3
-
34
-
-
79955471557
-
Cost-effectiveness of outpatient treatment for febrile neutropaenia in adult cancer patients
-
10.1038/bjc.2011.101 1:STN:280:DC%2BC3MvmvVejtA%3D%3D
-
Teuffel E, Amir, Alibhai S et al (2011) Cost-effectiveness of outpatient treatment for febrile neutropaenia in adult cancer patients. B JCancer 104:1377-1383
-
(2011)
B JCancer
, vol.104
, pp. 1377-1383
-
-
Teuffel, E.1
Amir2
Alibhai, S.3
-
35
-
-
39149137569
-
Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia
-
18235119 10.1200/JCO.2007.13.8222
-
Elting L, Lu C, Escalante C et al (2008) Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia. J Clin Oncol 26:606-611
-
(2008)
J Clin Oncol
, vol.26
, pp. 606-611
-
-
Elting, L.1
Lu, C.2
Escalante, C.3
-
36
-
-
80054736109
-
Safety of early discharge for low-risk patients with febrile neutropenia: A multicenter randomized controlled trial
-
21931024 10.1200/JCO.2011.35.0884
-
Talcott J, Yeap B, Clark J et al (2011) Safety of early discharge for low-risk patients with febrile neutropenia: a multicenter randomized controlled trial. J Clin Oncol 29:3977-3988
-
(2011)
J Clin Oncol
, vol.29
, pp. 3977-3988
-
-
Talcott, J.1
Yeap, B.2
Clark, J.3
-
37
-
-
80054740621
-
Costs of home versus inpatient treatment for fever and neutropenia: Analysis of a multicenter randomized trial
-
21931037 10.1200/JCO.2011.35.1247
-
Hendricks A, Trice Loggers E, Talcott J (2011) Costs of home versus inpatient treatment for fever and neutropenia: analysis of a multicenter randomized trial. J Clin Oncol 29:3984-3988
-
(2011)
J Clin Oncol
, vol.29
, pp. 3984-3988
-
-
Hendricks, A.1
Trice Loggers, E.2
Talcott, J.3
-
38
-
-
84868459981
-
Health-related quality of life anticipated with different management strategies for febrile neutropenia in adult cancer patients
-
22350594 10.1007/s00520-012-1397-8 1:STN:280:DC%2BC38vjs1Kmuw%3D%3D
-
Teuffel O, Cheng S, Ethier M et al (2012) Health-related quality of life anticipated with different management strategies for febrile neutropenia in adult cancer patients. Support Care Cancer 20(11):2755-2764
-
(2012)
Support Care Cancer
, vol.20
, Issue.11
, pp. 2755-2764
-
-
Teuffel, O.1
Cheng, S.2
Ethier, M.3
-
39
-
-
84055200503
-
Parental perspectives on inpatient versus outpatient management of pediatric febrile neutropenia
-
22194148 10.1177/1043454211418665
-
Diorio C, Martino J, Boydell K et al (2011) Parental perspectives on inpatient versus outpatient management of pediatric febrile neutropenia. J Pediatr Oncol Nurs 28:355-362
-
(2011)
J Pediatr Oncol Nurs
, vol.28
, pp. 355-362
-
-
Diorio, C.1
Martino, J.2
Boydell, K.3
-
40
-
-
84863985263
-
Outpatient and oral antibiotic management of low-risk febrile neutropenia are effective in children - A systematic review of prospective trials
-
22402749 10.1007/s00520-012-1425-8 1:STN:280:DC%2BC38vlvFynuw%3D%3D
-
Manji A, Beyene J, Dupuis R et al (2012) Outpatient and oral antibiotic management of low-risk febrile neutropenia are effective in children - a systematic review of prospective trials. Support Care Cancer 20:1135-1145
-
(2012)
Support Care Cancer
, vol.20
, pp. 1135-1145
-
-
Manji, A.1
Beyene, J.2
Dupuis, R.3
-
41
-
-
84860254785
-
Discrete choice experiment produced estimates of acceptable risks of therapeutic options in cancer patients with febrile neutropenia
-
22424607 10.1016/j.jclinepi.2011.11.008
-
Sung L, Alibhai S, Ethier MC et al (2012) Discrete choice experiment produced estimates of acceptable risks of therapeutic options in cancer patients with febrile neutropenia. J Clin Epidemiol 65:627-634
-
(2012)
J Clin Epidemiol
, vol.65
, pp. 627-634
-
-
Sung, L.1
Alibhai, S.2
Ethier, M.C.3
-
42
-
-
38349095054
-
Clinical practice patterns of managing low-risk adult febrile neutropenia during cancer chemotherapy in the USA
-
17943327 10.1007/s00520-007-0308-x
-
Freifeld A, Sankaranarayanan J, Ullrich F et al (2008) Clinical practice patterns of managing low-risk adult febrile neutropenia during cancer chemotherapy in the USA. Support Care Cancer 16:181-191
-
(2008)
Support Care Cancer
, vol.16
, pp. 181-191
-
-
Freifeld, A.1
Sankaranarayanan, J.2
Ullrich, F.3
-
43
-
-
0027300930
-
Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer
-
8490912 10.1002/1097-0142(19930601)71:11<3640: AID- CNCR2820711128>3.0.CO;2-H 1:STN:280:DyaK3s3lvVOntw%3D%3D
-
Rubenstein EB, Rolston K, Benjamin RS et al (1993) Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer. Cancer 71:3640-3646
-
(1993)
Cancer
, vol.71
, pp. 3640-3646
-
-
Rubenstein, E.B.1
Rolston, K.2
Benjamin, R.S.3
-
44
-
-
34848845798
-
Bacteraemia in febrile neutropenic cancer patients
-
17689933 10.1016/j.ijantimicag.2007.06.012 1:CAS:528:DC%2BD2sXhtFeitLvP
-
Klastersky J, Ameye L, Maertens et al (2007) Bacteraemia in febrile neutropenic cancer patients. Int J Antimicrob Agents 30(Suppl 1):S51-S59
-
(2007)
Int J Antimicrob Agents
, vol.30
, Issue.SUPPL. 1
-
-
Klastersky, J.1
Ameye, L.2
Maertens3
-
45
-
-
1842831404
-
Patients neutropéniques fébriles à bas et haut risques
-
10.1016/S0755-4982(04)98634-4
-
Blot F, Nitenberg G (2004) Patients neutropéniques fébriles à bas et haut risques. Presse Med 33:473-479
-
(2004)
Presse Med
, vol.33
, pp. 473-479
-
-
Blot, F.1
Nitenberg, G.2
-
46
-
-
84859057522
-
Management of febrile neutropenia in an acute oncology service
-
10.1093/qjmed/hcr217 1:STN:280:DC%2BC38znsVCjtg%3D%3D
-
Sammut S, Mazhar D (2012) Management of febrile neutropenia in an acute oncology service. Q J Med 105:327-336
-
(2012)
Q J Med
, vol.105
, pp. 327-336
-
-
Sammut, S.1
Mazhar, D.2
-
47
-
-
77950952140
-
Febrile neutropenia in French emergency departments: Results of a prospective multicentre survey
-
20403164 10.1186/cc8972
-
André S, Taboulet P, Elie C (2010) Febrile neutropenia in French emergency departments: results of a prospective multicentre survey. Crit Care 14:R68
-
(2010)
Crit Care
, vol.14
-
-
André, S.1
Taboulet, P.2
Elie, C.3
-
48
-
-
81755176060
-
Febrile neutropenia in EDs: The role of an electronic clinical practice guideline
-
21030183 10.1016/j.ajem.2010.08.011 11, 11.e1-5
-
Lim C, Bawden J, Wing A et al (2012) Febrile neutropenia in EDs: the role of an electronic clinical practice guideline. Am J Emerg Med 30(1):5, 11, 11.e1-5
-
(2012)
Am J Emerg Med
, vol.30
, Issue.1
-
-
Lim, C.1
Bawden, J.2
Wing, A.3
-
49
-
-
0035829842
-
Early goal-directed therapy in the treatment of severe sepsis and septic shock
-
11794169 10.1056/NEJMoa010307 1:STN:280:DC%2BD38%2FmsFGjtA%3D%3D
-
Rivers E, Nguyen B, Havstad S et al (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368-1377
-
(2001)
N Engl J Med
, vol.345
, pp. 1368-1377
-
-
Rivers, E.1
Nguyen, B.2
Havstad, S.3
-
50
-
-
80051596038
-
Predictive factors of poor prognosis in cancer patients with chemotherapy-induced febrile neutropenia
-
20552376 10.1007/s00520-010-0928-4
-
Ahn S, Lee YS, Chun YH et al (2011) Predictive factors of poor prognosis in cancer patients with chemotherapy-induced febrile neutropenia. Support Care Cancer 19:1151-1158
-
(2011)
Support Care Cancer
, vol.19
, pp. 1151-1158
-
-
Ahn, S.1
Lee, Y.S.2
Chun, Y.H.3
-
51
-
-
84859832879
-
The usefulness of procalcitonin and C-reactive protein as early diagnostic markers of bacteremia in cancer patients with febrile neutropenia
-
22022295 10.4143/crt.2011.43.3.176
-
Kim D, Lee YS, Ahn S et al (2011) The usefulness of procalcitonin and C-reactive protein as early diagnostic markers of bacteremia in cancer patients with febrile neutropenia. Cancer Res Treat 43:176-180
-
(2011)
Cancer Res Treat
, vol.43
, pp. 176-180
-
-
Kim, D.1
Lee, Y.S.2
Ahn, S.3
-
52
-
-
35348978703
-
Prediction of outcome in cancer patients with febrile neutropenia: Comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1β, -6 and -10
-
10.1111/j.1365-2354.2007.00780.x 1:STN:280:DC%2BD2snitVKmtg%3D%3D
-
Uys A, Rapoport B, Meyer P et al (2007) Prediction of outcome in cancer patients with febrile neutropenia: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1β, -6 and -10. Eur J Cancer Care (Engl) 16:475-483
-
(2007)
Eur J Cancer Care (Engl)
, vol.16
, pp. 475-483
-
-
Uys, A.1
Rapoport, B.2
Meyer, P.3
-
53
-
-
77953709282
-
Elevation in serum lactate at the time of febrile neutropenia (FN) in hemodynamically-stable patients with hematologic malignancies (HM) is associated with the development of septic shock within 48 h
-
20160493 10.4161/cbt.9.8.11270 1:CAS:528:DC%2BC3cXhtlKgtrbE
-
Mato A, Luger S, Heitjan D et al (2010) Elevation in serum lactate at the time of febrile neutropenia (FN) in hemodynamically-stable patients with hematologic malignancies (HM) is associated with the development of septic shock within 48 h. Cancer Biol Ther 9:585-589
-
(2010)
Cancer Biol Ther
, vol.9
, pp. 585-589
-
-
Mato, A.1
Luger, S.2
Heitjan, D.3
-
54
-
-
35748936767
-
Predictive factors of septic shock and mortality in neutropenic patients
-
10.1080/10245330701384237
-
Jeddi R, Zarrouk M, Benabdennebi Y et al (2007) Predictive factors of septic shock and mortality in neutropenic patients. Hematology 12:543-548
-
(2007)
Hematology
, vol.12
, pp. 543-548
-
-
Jeddi, R.1
Zarrouk, M.2
Benabdennebi, Y.3
-
55
-
-
84873238412
-
Incidence and impact of baseline electrolyte abnormalities in patients admitted with chemotherapy induced febrile neutropenia
-
21326626 10.7150/jca.2.62
-
Shaikh AJ, Bawany SA, Masood N et al (2011) Incidence and impact of baseline electrolyte abnormalities in patients admitted with chemotherapy induced febrile neutropenia. J Cancer 2:62-66
-
(2011)
J Cancer
, vol.2
, pp. 62-66
-
-
Shaikh, A.J.1
Bawany, S.A.2
Masood, N.3
-
56
-
-
67651204770
-
Evaluation of the risk factors for febrile neutropenia associated with hematological malignancy
-
19554402 10.1007/s10156-009-0683-y
-
Nakagawa Y, Suzuki K, Masaoka T (2009) Evaluation of the risk factors for febrile neutropenia associated with hematological malignancy. J Infect Chemother 15:174-179
-
(2009)
J Infect Chemother
, vol.15
, pp. 174-179
-
-
Nakagawa, Y.1
Suzuki, K.2
Masaoka, T.3
-
57
-
-
77649189452
-
The suggestion of a risk stratification system for febrile neutropenia in patients with hematologic disease
-
19762083 10.1016/j.leukres.2009.08.024
-
Park Y, Kim D, Park S et al (2010) The suggestion of a risk stratification system for febrile neutropenia in patients with hematologic disease. Leuk Res 34:294-300
-
(2010)
Leuk Res
, vol.34
, pp. 294-300
-
-
Park, Y.1
Kim, D.2
Park, S.3
-
58
-
-
44949102248
-
Performance of a modified MASCC index score for identifying low-risk febrile neutropenic cancer patients
-
10.1007/s00520-007-0347-3
-
De Souza VL, Serufo JC, da Costa Rocha MO et al (2008) Performance of a modified MASCC index score for identifying low-risk febrile neutropenic cancer patients. Support Care Cancer 16:841-846
-
(2008)
Support Care Cancer
, vol.16
, pp. 841-846
-
-
De Souza, V.L.1
Serufo, J.C.2
Da Costa Rocha, M.O.3
-
59
-
-
83255184514
-
Clinical factors predicting bacteremia in low-risk febrile neutropenia after anti-cancer chemotherapy
-
10.1007/s00520-010-1017-4
-
Eun Ha Y, Song JH, Kang WK et al (2011) Clinical factors predicting bacteremia in low-risk febrile neutropenia after anti-cancer chemotherapy. Support Care Cancer 19:1761-1767
-
(2011)
Support Care Cancer
, vol.19
, pp. 1761-1767
-
-
Eun Ha, Y.1
Song, J.H.2
Kang, W.K.3
-
60
-
-
77957815662
-
Multiplex blood PCR in combination with blood cultures for improvement of microbiological documentation of infection in febrile neutropenia
-
20720024 10.1128/JCM.00147-10 1:STN:280:DC%2BC3cfmsFGhtA%3D%3D
-
Lamoth F, Jaton K, Prod'hom G et al (2010) Multiplex blood PCR in combination with blood cultures for improvement of microbiological documentation of infection in febrile neutropenia. J Clin Microbiol 48:3510-3516
-
(2010)
J Clin Microbiol
, vol.48
, pp. 3510-3516
-
-
Lamoth, F.1
Jaton, K.2
Prod'Hom, G.3
-
61
-
-
80052088844
-
High pentraxin 3 level predicts septic shock and bacteremia at the onset of febrile neutropenia after intensive chemotherapy of hematologic patients
-
21880642 10.3324/haematol.2011.044925
-
Vänskä M, Koivula I, Hämäläinen S et al (2011) High pentraxin 3 level predicts septic shock and bacteremia at the onset of febrile neutropenia after intensive chemotherapy of hematologic patients. Haematologica 96:1385-1389
-
(2011)
Haematologica
, vol.96
, pp. 1385-1389
-
-
Vänskä, M.1
Koivula, I.2
Hämäläinen, S.3
-
62
-
-
79955430154
-
Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapy
-
21509769 10.1002/cncr.25691
-
Lyman G, Kuderer N, Crawford B et al (2011) Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapy. Cancer 117:1917-1927
-
(2011)
Cancer
, vol.117
, pp. 1917-1927
-
-
Lyman, G.1
Kuderer, N.2
Crawford, B.3
-
63
-
-
61649126029
-
A general chemotherapy myelotoxicity score to predict febrile neutropenia in hematological malignancies
-
19139177 10.1093/annonc/mdn655 1:STN:280:DC%2BD1M7mvVOmsw%3D%3D
-
Moreau M, Klasterky J, Schwarzbold A et al (2009) A general chemotherapy myelotoxicity score to predict febrile neutropenia in hematological malignancies. Ann Oncol 20:513-519
-
(2009)
Ann Oncol
, vol.20
, pp. 513-519
-
-
Moreau, M.1
Klasterky, J.2
Schwarzbold, A.3
-
64
-
-
33644678723
-
Can we predict the duration of chemotherapy-induced neutropenia in febrile neutropenic patients, focusing on regimen-specific risk factors? A retrospective analysis
-
16322116 10.1093/annonc/mdj092 1:STN:280:DC%2BD287ht1Oktg%3D%3D
-
Lalami Y, Paesmans M, Muanza F et al (2006) Can we predict the duration of chemotherapy-induced neutropenia in febrile neutropenic patients, focusing on regimen-specific risk factors? A retrospective analysis. Ann Oncol 17:507-514
-
(2006)
Ann Oncol
, vol.17
, pp. 507-514
-
-
Lalami, Y.1
Paesmans, M.2
Muanza, F.3
-
65
-
-
33748974393
-
EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumors
-
16750358 10.1016/j.ejca.2006.05.002 1:CAS:528:DC%2BD28XhtVagtrbL
-
Aapro MS, Cameron DA, Pettengell R et al (2006) EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumors. Eur J Cancer 42:2433-2453
-
(2006)
Eur J Cancer
, vol.42
, pp. 2433-2453
-
-
Aapro, M.S.1
Cameron, D.A.2
Pettengell, R.3
-
66
-
-
74549210268
-
Advances in the treatment of neutropenia
-
19550332 10.1097/SPC.0b013e32832ea6ae
-
Dale C (2009) Advances in the treatment of neutropenia. Curr Opin Support Palliat Care 3:207-212
-
(2009)
Curr Opin Support Palliat Care
, vol.3
, pp. 207-212
-
-
Dale, C.1
-
67
-
-
80053173427
-
Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: Systematic review and meta-analysis
-
21943360 10.1186/1471-2407-11-404 1:CAS:528:DC%2BC3MXhtlamu7vJ
-
Cooper K, Madan J, Whyte S et al (2011) Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis. BMC Cancer 11:404
-
(2011)
BMC Cancer
, vol.11
, pp. 404
-
-
Cooper, K.1
Madan, J.2
Whyte, S.3
-
68
-
-
84879687663
-
Febrile neutropenia (FN) in patients with solid tumors (St): Is the risk of complications affected by the type of chemotherapy?
-
Klastersky J, Georgala A, Ameye L et al (2010) Febrile neutropenia (FN) in patients with solid tumors (St): is the risk of complications affected by the type of chemotherapy? Support Care Cancer 18:S67-S220
-
(2010)
Support Care Cancer
, vol.18
-
-
Klastersky, J.1
Georgala, A.2
Ameye, L.3
-
69
-
-
67650309542
-
Should the indications for the use of myeloid growth factors for the prevention of febrile neutropenia in cancer patients be extended?
-
19509500 10.1097/CCO.0b013e32832c9651 1:CAS:528:DC%2BD1MXnsVeiurw%3D
-
Klastersky J, Awada A, Aoun M et al (2009) Should the indications for the use of myeloid growth factors for the prevention of febrile neutropenia in cancer patients be extended? Curr Opin Oncol 21:297-302
-
(2009)
Curr Opin Oncol
, vol.21
, pp. 297-302
-
-
Klastersky, J.1
Awada, A.2
Aoun, M.3
-
70
-
-
27244449783
-
Impact of five prophylactic filgrastim schedules on hematologic toxicity in early breast cancer patients treated with epirubicin and cyclophosphamide
-
16129844 10.1200/JCO.2005.03.099 1:CAS:528:DC%2BD2MXhtFCrsbrE
-
Papaldo P, López M, Marolla P et al (2005) Impact of five prophylactic filgrastim schedules on hematologic toxicity in early breast cancer patients treated with epirubicin and cyclophosphamide. J Clin Oncol 23:6908-6918
-
(2005)
J Clin Oncol
, vol.23
, pp. 6908-6918
-
-
Papaldo, P.1
López, M.2
Marolla, P.3
|